| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3155069b833b184bcd4ad12f7100dd4c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate |
2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6dfde9cdffe09b0d2a0365b198cbb48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eec5a7f570c9bbb24d0a9ef6091a368b |
| publicationDate |
2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020028819-A1 |
| titleOfInvention |
Compositions and methods for improving ovarian tumor cell sensitivity to drugs |
| abstract |
The present invention provides a method of treating cancer in a subject. In certain embodiments, the method comprises administering to the subject a claudin blocking/disrupting agent and at least one additional compound. In other embodiments, the at least one additional compound is a chemotherapeutic agent including but not limited to paclitaxel. |
| priorityDate |
2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |